ARTICLE | Company News
Cepheid sales and marketing update
March 30, 2009 7:00 AM UTC
Cepheid will launch its Xpert MTB/RIF test in Europe next month to diagnose Mycobacterium tuberculosis (TB) infection and determine its susceptibility to rifampicin. The test will run on Cepheid's Gen...